As of 2025-12-20, the Relative Valuation of Rubius Therapeutics Inc (RUBY) is (68.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Rubius Therapeutics Inc based on Relative Valuation is -82997.1%.
The range of the Relative Valuation is (60.89) - (67.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 23.4x | 21.0x |
| Forward P/E multiples | 21.0x - 32.0x | 26.5x |
| Fair Price | (60.89) - (67.60) | (68.80) |
| Upside | -73460.9% - -81550.1% | -82997.1% |
| Date | P/E |